Article
A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Nov 2013
Grant Jon E, Odlaug Brian L, Chamberlain Samuel R, Hampshire Adam, Schreiber Liana R N, Kim Suck Won
Abstract excerpt
Pathological gambling (PG) is a disabling disorder experienced by 1-3% of adults, and empirically validated treatments are lacking. Perturbations of prefrontal-dependent cognitive functions are implicated in the pathophysiology of PG. The enzyme catechol-O-methyl-transferase (COMT) is responsible for degradation of dopamine in the cortices and thereby is known to regulate such cognitive functions and their neural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
